Dinoprost tromethamine

Dinoprost tromethamine is a synthetic form of prostaglandin F2α (PGF2α), which is a naturally occurring hormone involved in various physiological processes in the body. It is used in medicine primarily for its potent uterotonic properties, meaning it can induce contractions in the uterus. This makes it useful in certain gynecological and obstetric procedures, such as inducing labor, managing postpartum hemorrhage, and in the treatment of nonviable pregnancy.

Medical Uses

Dinoprost tromethamine is indicated for use in several clinical scenarios:

• Induction of labor in pregnant women who have a medical necessity for the initiation of labor.
• Treatment of postpartum hemorrhage, which is excessive bleeding following childbirth.
• Management of nonviable pregnancies, including missed miscarriage and intrauterine fetal death.

Mechanism of Action

Dinoprost tromethamine works by mimicking the action of natural prostaglandin F2α. Prostaglandins are involved in various processes in the body, including the induction of labor. They work by binding to specific receptors on the uterine muscle, causing it to contract. This action helps in the expulsion of the fetus during labor and helps control bleeding by contracting the uterine muscles after childbirth.

Administration

This medication is typically administered via injection directly into the muscle (intramuscularly) or into the amniotic sac (intra-amniotically), depending on the specific indication and clinical scenario.

Side Effects

Like all medications, dinoprost tromethamine can cause side effects, although not everyone experiences them. Common side effects include:

• Nausea and vomiting
• Diarrhea
• Fever
• Headache
• Uterine cramping

Severe side effects can include:

• Excessive uterine bleeding
• Uterine rupture
• Anaphylactic reactions

Patients should be monitored closely for signs of adverse reactions, especially when administered for inducing labor or treating postpartum hemorrhage.

Contraindications

Dinoprost tromethamine is contraindicated in patients with:

• Active cardiovascular, pulmonary, renal, or hepatic disease
• Hypersensitivity to dinoprost tromethamine or any of its components
• Conditions where the induction of labor is not advisable, such as abnormal fetal position or placental abnormalities

Pharmacokinetics

The pharmacokinetic properties of dinoprost tromethamine include rapid absorption and onset of action when administered intramuscularly. It is metabolized primarily in the lungs and excreted in the urine.

See Also

• Prostaglandin
• Labor induction
• Postpartum hemorrhage
• Miscarriage

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian